• Perspectives: Mainstreaming Alternative Medicines: Botanicals and Other Complex Natural Products as Prescription Drugs
  
• Hormones and their Relationships to Epilepsy and Pre-Menstrual Disorders in Young Women
  
• Perspectives: Hybrid Cell Silicon Neural Implants
  
• Epilepsy and Disability – An International Consensus Conclave
  
• Perspectives: Developing a hybrid neuroprosthesis for epilepsy treatment
  
• Perspectives on Drug and Medical Device Development: 2007
  
• Stability of Mood Symptoms in Adults with Epilepsy
  An Interview with Cynthia Harden, MD
  
• Childhood Epilepsy and Impact on Family (AES Abstract)
  An Interview with Carol Camfield, MD, FRCP(C)
  
• Epilepsy.com Reports from AES
  
• 2007 American Epilepsy Society Meeting Notes
  
• Mission Accomplished: Senator John Kerry May Be Putting Small Biotechs in Jeopardy
  
• Unmet Medical Needs for People with Epilepsy
  
• Perspectives: Neurotechnology Leaves the Nest, Awaiting a Policy Push
  
• Medication alert – Why the new Dilantin® 100 mg. Capsules?
  
• Work in Epilepsy Innovation Research:
  A Highlight for CIMIT Congress
  
• Pregnancy Registries
  Release of Negative Information
  
• Caring for Our Veterans with Traumatic Brain Injury at Risk for Developing Epilepsy
  
• Health Outcomes in Pregnancy and Epilepsy (HOPE)
  
• Epidemiology and Ethics, Scientific Integrity, Regulatory Control Working Groups
  
• Health Outcomes in Pregnancy and Epilepsy (HOPE)
  
• Basic Principles of Study Design
  
• Sleep, Seizures, and the Effects of Medication
  
• Drug Price Soars from $1,650 to $23,000 Per Vial
  To Treat Babies with Infantile Spasms: Parents and Physicians React
  
• Operation Giveback: Giving Veterans the Care They Need and Deserve
  An Interview with Marc A. Dichter, MD, PhD
  
• Perspectives | The 2007 NIH Budget for Epilepsy Research: Is it Time To Get Involved?
  
• Profiles of Epilepsy Research Foundation Translational Research Award Recipients
  
• Funding to Advance Innovative Epilepsy Therapies is Spearheaded by Epilepsy Therapy Development Project
  
• Chief Justice John Roberts
  
• To Sleep, Perchance to Dream
  
• The Survey Results: Does Limited Transportation Impact Medical Compliance?
  An Interview with Professor Timothy Welty
  aed, pharmacy, driving, findings, survey, medication, on time
• Perspectives | Finding Seizure Drugs Anywhere in the World
  
• AED IX - Highlights of Day Two: Special Considerations with AEDs for Children, the Elderly, and Women
  
• AED IX - Highlights of Day Three: Updates on Drugs in the Pipeline
  
• AED IX - Highlights of Day One: New Drugs in the Future for Persons with Epilepsy
  
• Junior Investigators Talk about Curing Epilepsy 2007
  
• The World of Epilepsy, a People’s Guide to Understanding Epilepsy
  An Interview with Roy Sucholeiki, MD
  
• Modified Atkins diet – More on the Plate!
  How does the modified Atkins diet compare to the Ketogenic diet.
• Can patients with epilepsy predict their seizures?
  An Interview with Sheryl R. Haut, MD
  Dr Haut tells us how she proceeded with her tests and how those results will help the next phase of the study.
• Battling Epilepsy, and Its Stigma
  
• An Interview with Jacqueline French, MD, Symposium Director
  Ninth Antiepileptic Drug Trials Conference
  
• Meet the Leaders of the National Initiative for Children’s Healthcare Quality
  An interview with Dr. Charles Homer and Sarah S. Bloor
• Localizing Seizure Activity - An Interview with Hal Blumenfeld, MD, PhD
  
• Making a Documentary that Makes a Difference for People Living with Epilepsy
  
• The Eighth Eilat Conference on New Antiepileptic Drugs: A Report and Conversation with Drs. Jackie French and Steven Schachter
  
• Special Editorial: The Risks and Benefits of Epilepsy Medication During Pregnancy
  
• Approval of (Lamictal™) lamotrigine by the FDA as adjunctive treatment for primary generalized tonic-clonic seizures in children and adults. How does it impact care?
  
• New Study Highlights Decreased Quality of Life in Patients with Epilepsy and Comorbid Medical and Psychiatric Conditions
  
• New Study Reveals Link Between Valproate and Birth Defects
  
• Tuberous Sclerosis Complex: Exploring the Complexities
  
• FIREWORKS and EPILEPSY
  
• Meditation & Epilepsy: The Silent Debate Wages On
  
• Next Generation of Epilepsy Researchers includes U. of Alabama’s Cody Locke
  
• Study Identifies Predictors for Employment After Epilepsy Surgery
  The best predictor for gainful employment postsurgically is to have been working before surgery,” said Andres Kanner, MD, Professor of Neurological Sciences, Rush Medical College, Chicago, Ill, at the 58th Annual Meeting of the American Academy of Neurolo
• Young Children Less Likely to Gain Weight from Valproate
  Children younger than 12 years of age did not gain weight on valproate, according to the results of a retrospective study presented by Patricio Espinosa, MD, MPH at this year’s 58th Annual Meeting of the American Academy of Neurology held in San Diego.
• QOLIE-89 Misses Impact of Obstructive Sleep Apnea on Quality of Life
  Quality of life in people with intractable epilepsy, as measured by the QOLIE-89 questionnaire, is not affected by symptoms of sleep apnea...
• Ovulation Failure Linked to Increased Seizure Frequency
  Dr. Andrew Herzog and colleagues present their latest findings regarding ovulatory dysfunction in women with epilepsy.
• Long-Term Effects of the Ketogenic Diet
  Seizure control with the ketogenic diet may come at a price, according to a retrospective review presented by Darcy Groesbeck at this year’s 58th annual meeting of the American Academy of Neurology.
• Implantable Devices Could Stop Seizures in Their Tracks
  The latest implantable devices and mechanisms for the treatment of epilepsy.
• Sudden Unexplained Death in Epilepsy: What Coroners and Medical Examiners Aren’t Saying
  Exploring the latest research regarding coroner and medical examiner documentation of sudden unexplained deaths in epilepsy.
• Shedding Light on Photosensitivity, One of Epilepsy’s Most Complex Conditions
  Dr. Guiseppe Erba explores the relationship between photosensitivity and epilepsy.
• Cognitive Improvement Makes the List as Common Treatment Goal for Parents of Children with Intractable Epilepsy
  Researchers at Johns Hopkins Children’s Center recently found that cognitive improvement is one of the most common goals of parents with children with intractable epilepsy prior to starting the ketogenic diet.
• Taking Epilepsy Care to a Whole New Level
  Dr. James Wheless discusses how to take a comprehensive epilepsy center from a Level I to a Level IV.
• AEDs: New Approaches to Discovery and New Challenges to Commercialization
  
• Botanicals Take Center Stage at AES
  Leading researchers met to discuss the use of botanicals and herbs as treatment for epilepsy.
• Professionals in Epilepsy Care Symposium:Controversies and Challenges of EEG Monitoring
  
• Understanding Medicare Part D
  Patricia Osborne Shafer RN, MN, Resource Specialist for epilepsy.com, dispels the confusion surrounding Medicare Part D.
• Does Treatment Aggressiveness Affect the Prognosis of Refractory Status Epilepticus?
  How does treatment aggressiveness affect the prognosis of RSE? This is the question Edward Bromfield, M.D, Brigham & Women’s Hospital and Harvard Medical School, Andrea Rossetti, M.D., Swiss National Science Foundation, and Giancarlo Logroscino, M.D., PhD
• Just What Are Treatment Goals for People Living with Epilepsy?
  Dr. Melanie Adams presents her latest findings, at the American Epilepsy Society 59th Annual meeting, regarding treatment goals for people living with epilepsy.
• Exploring the Relationship between Insomnia and AEDs
  Dr. Carl Bazil and colleagues, present their latest research findings regarding insomnia and antiepileptic drugs at the American Epilepsy Society 59th Annual Meeting in Washington DC.
• The Impact of Maternal Anxiety on the Adaptive Functioning of Children with Epilepsy
  Lynn Chapieski, Ph.D, and colleagues explore the relationship between maternal anxiety and adaptive behavior in children with epilepsy.
• Older Adults with Epilepsy: The Latest Research
  The latest research exploring the concerns of older adults with epilepsy.
• A Commentary on the Use of Prolactin Serum in Diagnosing Epileptic Seizures
  Dr. W. Curt LaFrance comments on the use of prolactin serum in diagnosing epileptic seizures.
• Neurophysiology: Dust Clearing on the Long-Term Potentiation Debate
  Convergence Emerges on LTP mechanisms-well almost
  An almost decade-long argument over whether LTP should be considered presynaptic or postsynaptic now appears to be settled, allowing researchers to pursue the finer details.
• Commentary on Long-Term Potentiation Debate
  Dr. Orrin Devinsky comments on the LTP debate recently explored in an article published in The Scientist, entitled Neurophysiology: Dust CLearing on the Long-Term Potentiation Debate Convergence Emerges on LTP mechanisms-well almost.
• The Truth About Psychogenic NonEpileptic Seizures
  The controversial subject of PNES is explored in-depth through interviews with leading experts in the field including Selim Benbadis, M.D.
• FDA’s New Drug Safety Plan Under the Microscope
  The FDA's new drug safety plan leaves many skeptical and wondering if it will be sufficient to quell drug safety fears.
• The Clinical Issues Facing Neurologists Today
  Dr. Nathan Fountain dissects the treatment issues facing neurologists today with an emphasis on evidence-based medicine.
• Review and Commentary on Epilepsy and the Elderly
  Dr. Mark Spitz,University of Colorado, Department of Neurology, comments on the latest research regarding the incidence of epilepsy in seniors as well as diagnosis and treatment issues.
• Acute Repetitive Seizures and Seizure Emergencies: Weighing Your Treatment Options
  Exploring both FDA approved and off-label therapy options in the treatment of acute repetetive seizures.
• The Fluid Percussion Model: An Interview with Dr. Raimondo D'Ambrosio
  An interview with Raimondo D'Ambrosio regarding the fluid percussion model.
• The Atkins Diet: A New Treatment for Intractable Epilepsy?
  New data from study at John's Hopkins Children's Center shows Atkins Diet as an effective treatment for intractable epilepsy.
• Success of Pediatric Epilepsy Surgery Has Long Term Social Effects
  An interview with Lucyna Lach regarding her findings on the long term social outcomes of pediatric epilepsy surgery as presented at the 58th annual AES conference in New Orleans.
• Assessing Cognitive and Behavioral Outcomes of AEDs
  Issues related to the assessment of cognitive and behavioral outcomes of therapy with antiepileptic drugs (AEDs) were discussed in a workshop held at the 58th annual AES conference.
• Progression in Temporal Lobe Epilepsy
  An interview with Dr. Hermann regarding his most recent research on progression in temporal lobe epilepsy (TLE)
• Uncontrolled Epilepsy Following Discontinuation of Antiepileptic Drugs in Seizure-Free Patients
  Drs. Schmidt and Löscher explore the long-term course of epilepsy following a recurrence after planned AED discontinuation.
• New Antiepileptic Device May Control Seizures
  
• New Findings Reveal Suicidal Behavior in Children with Epilepsy
  Dr. Rochelle Caplan presents her latest findings on the suicidal behavior in children with epilepsy at the 58th annual American Epilepsy Society conference in New Orleans.
• Obstructive Sleep Apnea: Which Epilepsy Patients are at Greatest Risk?
  Today at the at the 58th annual American Epilepsy Society conference in New Orleans, Beth A. Malow, M.D., Vanderbilt University, and colleagues reported on the clinical characteristics that are predictive of obstructive sleep apnea (OSA) on polysomnograph
• Levetiracetam Study Yields New Hope For Children with Partial Onset Seizures
  Dr. Tracy Glauser presents his most recent findings on the use of Levetiracetam (Keppra) as an adjunctive (add-on) treatment for children with partial onset seizures.
• Case Management in Epilepsy: The New Health Care Paradigm
  Dr. William O Tatum IV presents his latest findings in relation to case managemnt as another paradigm of care for patients with epilepsy.
• Clinical Drug Study Participation Improves Seizure Frequency
  "Seizure frequency improves in patients with epilepsy participating in clinical drug studies even when they do not continue to receive the experimental drug,”
• Study Shows Remission in a Refractory Adult Epilepsy Population Is Possible
  Dr. Jacqueline French presents her findings on what treatment changes or additions lead to remission in patients with well-defined refractory adult epilepsy.
• Pregabalin: New Add-On Treatment for Partial Onset Seizures
  Dr. Jacqueline French presents her findings regarding Pregabalin as an effective add-on therapy for patients with partial-onset seizures.
• Female Hormone Replacement Therapy May Increase Seizure Frequency
  Dr. Cynthia Harden explores use of Prempro to treat menopausal women with epilepsy.
• Lamotrigine Proves To Be Effective Add-On Therapy
  Joyce Cramer presents her latest findings regarding the use of lamotrigine (LTG) as an adjunctive therapy to other antiepileptic drugs (AEDs) and its effect on mood states.
• Sleep Disorders in Pediatric Population: More Common than You Think
  Past research conducted in the field of childhood epilepsy has clearly shown a link between behavioral problems and epilepsy. But, what if these behavioral problems in children with epilepsy could be attributed in part to sleep related difficulties?
• New Clinical Findings Suggest Abnormal Activation of Language Cortex in Patients with Chronic Epilepsy
  Neuropsychologist, Joshua Breier presented his most recent findings from a retrospective study he and several colleagues conducted exploring abnormal activation of language cortex in patients with chronic seizures and academic achievement deficit.
• Treatment of New Onset Epilepsy
  The two major organizations for professionals with an interest in epilepsy have come to a consensus on the use of antiepileptic drugs (AEDs) for new onset epilepsy
• High Incidence of Depression Among People with Epilepsy
  Epilepsy extends beyond seizures and need not be compounded with the stigma of untreated depression.

Back to top